The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
Aragen, a leading CRDMO specializing in small molecules and biologics, is establishing a new biologics manufacturing facility in Bangalore, India
The facility aims to produce cell and gene therapies on a global scale, making them more accessible worldwide
Sandozs investment sets the stage for a significant transformation of the Ljubljana site into a central hub for advancing biosimilar products within the company
The Novo Nordisk Foundation is embarking on a groundbreaking journey, dedicating its resources to forge a stateoftheart facility that will serve as the ultimate crucible
McCord Development is strengthening its presence in the life sciences and biomanufacturing sector with the launch of BioHub Two
ST Pharm invests US$110 million to open new stateoftheart Oligonucleotide facility at Banwol campus, South Korea
Sandozs investment sets the stage for a significant transformation of the Ljubljana site into a central hub for advancing biosimilar products within the company
Prominent contract development and manufacturing organization CDMO, Biovian Oy, known for its expertise in biopharmaceuticals, announces a significant upgrade to its Turku manufacturing facility
The expansion will involve the addition of 98,000 square feet of lab space and production capability specifically for manufacturing cell culture media
Aurigene Pharmaceutical Services a subsidiary of Dr Reddys Laboratories plans to invest US$40 million to construct new stateofthe art development and manufacturing facility in Hyderabad
